Skip to main content
. Author manuscript; available in PMC: 2014 Aug 6.
Published in final edited form as: Lancet. 2010 Jun 30;376(9739):419–430. doi: 10.1016/S0140-6736(10)60576-4

Figure 4.

Figure 4

Hazard ratios comparing intensive to standard glycemia arm assignment for each microvascular outcome utilizing data until transition of intensive glycemia arm to standard therapy. Hazard ratios adjusted for baseline clinical cardiovascular disease history and second trial treatment arm assignment. Horizontal bars represent 95% confidence intervals.